Skip to main content

Table 2 Dyslipidemia rate and the characteristics

From: Prevalence of dyslipidemia, treatment rate and its control among patients with type 2 diabetes mellitus in Northwest China: a cross-sectional study

 

Normolipidemia

Dyslipidemia

P value

Non-treatment

Treatment

N (%)

152 (12.3%)

345 (28.1%)

734 (59.6%)

< 0.0001

Sex

male

92 (11.0%)

246 (29.4%)

500 (59.7%)

 

female

60 (15.3%)

99 (25.2%)

234 (59.5%)

0.0600

Age (years)

< 50

46 (12.5%)

189 (51.4%)

133 (36.1%)

 

50–60

57 (14.7%)

90 (23.3%)

240 (62.0%)

 

> 60

49 (10.3%)

66 (13.9%)

361 (75.8%)

< 0.0001

HbA1c (%)

< 7

49 (14.5%)

82 (24.3%)

207 (61.2%)

 

7–10

53 (9.2%)

153 (26.5%)

372 (64.4%)

 

> 10

50 (15.9%)

110 (34.9%)

155 (49.2%)

< 0.0001

T2DM duration (years)

< 3

33 (11.7%)

125 (44.5%)

123 (43.8%)

 

3–10

67 (13.8%)

151 (31.1%)

267 (55.1%)

 

> 10

52 (11.2%)

69 (14.8%)

344 (74.0%)

< 0.0001

BMI (kg/m2)

< 24

75 (20.5%)

74 (20.3%)

216 (59.2%)

 

≥ 24

77 (8.9%)

271 (31.3%)

518 (59.8%)

< 0.0001

Hypertension

Yes

62 (10.7%)

108 (18.7%)

409 (70.6%)

 

No

90 (13.8%)

237 (36.3%)

325 (49.8%)

< 0.0001

FLD

Yes

20 (6.5%)

97 (31.7%)

189 (61.8%)

 

No

132 (14.3%)

248 (26.8%)

545 (58.9%)

0.0010

  1. Values were frequency (percentage). P value was calculated by Chi-square test or Fisher’s exact test